FibroGen Inc (MEX:FGEN)
MXN 6.4 -0.01 (-0.16%) Market Cap: 598.78 Mil Enterprise Value: 711.97 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 44/100

Q1 2019 FibroGen Inc Earnings Call Transcript

May 09, 2019 / 09:00PM GMT
Release Date Price: MXN890
Operator

Welcome to the FibroGen First 2019 Financial Results Conference Call. My name is Erin, and I will be your operator for today's call. (Operator Instructions) Please note that this conference is being recorded. I will now turn the call over to Karen Bergman. Ms. Bergman, you may begin.

Karen L. Bergman
FibroGen, Inc. - VP of IR & Corporate Communications

Erin, thank you very much. And good afternoon, everyone, and thank you for joining our call. Today, we are reporting financial results and corporate updates for the first quarter of 2019.

Joining today's call are Mr. Tom Neff, Chairman and Chief Executive Officer; Dr. Peony Yu, Chief Medical Officer; Dr. Elias Kouchakji, Senior Vice President, Clinical Development, Drug Safety and Pharmacovigilance; and Mr. Pat Cotroneo, Chief Financial Officer.

Following prepared remarks, Tom will discuss upcoming milestones, and we'll open the call to Q&A.

During this call, you may -- we may make forward-looking statements regarding our business, including our collaborations with

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot